PNPLA3 I148M Variant Impairs Liver X Receptor Signaling and Cholesterol Homeostasis in Human Hepatic Stellate Cells

Hepatology Communications - United Kingdom
doi 10.1002/hep4.1395
Full Text
Abstract

Available in full text

Categories
Hepatology
Date
Authors
Publisher

Wiley

Related search

The PNPLA3 I148M Variant Modulates the Fibrogenic Phenotype of Human Hepatic Stellate Cells

Hepatology
MedicineHepatology
2017English

Hepatic Stellate Cells and Alcoholic Liver Disease

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2006English

The PNPLA3 Variant Associated With Fatty Liver Disease (I148M) Accumulates on Lipid Droplets by Evading Ubiquitylation

Hepatology
MedicineHepatology
2017English

Mutant PNPLA3 I148M Protein as Pharmacological Target for Liver Disease

Hepatology
MedicineHepatology
2017English

The Rs738409 (I148M) Variant of the PNPLA3 Gene and Type 2 Diabetes in Yakutia

International Journal of Biomedicine
2018English

Decoding the Role of the Nuclear Receptor SHP in Regulating Hepatic Stellate Cells and Liver Fibrogenesis

Scientific Reports
Multidisciplinary
2017English

Hematopoietic Origin of Hepatic Stellate Cells in the Adult Liver

Blood
BiochemistryImmunologyCell BiologyHematology
2008English

The Interplay of the Notch Signaling in Hepatic Stellate Cells and Macrophages Determines the Fate of Liver Fibrogenesis

Scientific Reports
Multidisciplinary
2015English

Cytoglobin Is Expressed in Hepatic Stellate Cells, but Not in Myofibroblasts, in Normal and Fibrotic Human Liver

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy